Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUYA
3276
Huya Inc
HUYA
$540M
| $723K | ﹤0.01% |
41,011
+3,825
| +10% | +$64.1K |
|
3277
Amplify Lithium & Battery Technology ETF
BATT
$125M
| $714K | ﹤0.01% |
+39,773
| New | +$645K |
|
|
HIMX
3278
Himax Technologies
HIMX
$2.64B
| $712K | ﹤0.01% |
42,664
+13,872
| +48% | +$183K |
|
3279
TriCo Bancshares
TCBK
$1.84B
| $712K | ﹤0.01% |
16,720
+154
| +0.9% | +$7.14K |
|
3280
ZTO Express
ZTO
$17.5B
| $712K | ﹤0.01% |
23,460
-321
| -1% | -$9.91K |
|
3281
John Hancock Multifactor Emerging Markets ETF
JHEM
$1.03B
| $708K | ﹤0.01% |
22,337
+9,708
| +77% | +$304K |
|
|
ATRI
3282
DELISTED
Atrion Corp
ATRI
| $707K | ﹤0.01% |
1,139
-13,739
| -92% | -$8.58M |
|
|
AFMD
3283
DELISTED
Affimed
AFMD
| $700K | ﹤0.01% |
8,231
+5,492
| +201% | +$501K |
|
3284
Equity Bancshares
EQBK
$1.06B
| $698K | ﹤0.01% |
22,900
| – | – |
|
|
RAD
3285
DELISTED
Rite Aid Corporation
RAD
| $695K | ﹤0.01% |
42,648
-1,521
| -3% | -$29.1K |
|
3286
Sana Biotechnology
SANA
$1.12B
| $694K | ﹤0.01% |
35,291
-200,768
| -85% | -$4.55M |
|
|
AMJ
3287
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $694K | ﹤0.01% |
35,305
-92,007
| -72% | -$1.71M |
|
3288
LifeMD
LFMD
$158M
| $686K | ﹤0.01% |
58,257
-2,270
| -4% | -$26.1K |
|
3289
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$362M
| $682K | ﹤0.01% |
15,060
-1,135
| -7% | -$50.6K |
|
3290
BOK Financial
BOKF
$8.76B
| $680K | ﹤0.01% |
7,850
-264
| -3% | -$23.6K |
|
3291
First Internet Bancorp
INBK
$255M
| $677K | ﹤0.01% |
21,867
+2,981
| +16% | +$101K |
|
3292
Alpha Teknova
TKNO
$376M
| $676K | ﹤0.01% |
+28,506
| New | +$721K |
|
3293
Lennar Class B
LEN.B
$20.3B
| $675K | ﹤0.01% |
8,726
-470
| -5% | -$35.5K |
|
3294
Vanguard Russell 2000 Growth ETF
VTWG
$1.56B
| $674K | ﹤0.01% |
2,969
+1,806
| +155% | +$396K |
|
|
TECX
3295
Tectonic Therapeutic
TECX
$652M
| $674K | ﹤0.01% |
6,319
+359
| +6% | +$42.6K |
|
|
AWF
3296
AllianceBernstein Global High Income Fund
AWF
$876M
| $670K | ﹤0.01% |
+53,547
| New | +$649K |
|
|
MMT
3297
Aberdeen Multi-Market Income Fund
MMT
$244M
| $669K | ﹤0.01% |
107,109
-3,877
| -3% | -$24.9K |
|
|
RPT
3298
Rithm Property Trust
RPT
$99.5M
| $669K | ﹤0.01% |
8,603
| – | – |
|
|
VTNR
3299
DELISTED
Vertex Energy, Inc
VTNR
| $668K | ﹤0.01% |
+50,500
| New | +$209K |
|
3300
MacroGenics
MGNX
$254M
| $666K | ﹤0.01% |
24,793
-116
| -0.5% | -$3.4K |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,726 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.